Peer Review History
| Original SubmissionJune 8, 2020 |
|---|
|
PONE-D-20-17494 Determinants of preterm birth among women delivered in public hospitals of Western Ethiopia, 2020: Unmatched case-control study PLOS ONE Dear Dr. Abadiga, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 29 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Florian Fischer Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In the manuscript text, please provide additional details regarding participant consent. Please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. 3.Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. In addition, in the Methods, please describe how the questionnaire was pre-tested and/or validated. If this did not occur, please provide the rationale for not pre-testing or validating the questionnaire. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Abstract It is good but the result and the conclusions needs a revision. The result does not show the association in clearly and the direction of association is not clear. In the conclusion, it lacks bold and clear suggestion for the policy and programmatic startegic implication of the study. Background The introduction has well written about the contexts. However, it lacks some depth about the reason why the need of conducting this study and in this section, the knowledge gap was not clearly explained clearly, how would the study help the country to increase attentions in PTB prevention and control strategies? At the same time, the literature the authors mentioned some research conducted on similar topic in the same country, method with only difference in districts. Hence, the researcher needs to justify and the passion of doing this as an additional interest. Methods • The researcher needs to mention and show the sampling done and the potential selection bias that might be introduced in the methodology. • In the analysis and model fitting-, how the researcher manage the small observation in the outcome variable particularly in the multiple regression is not well explained this might affect the final picture and findings of the findings. Therefore the researcher needs to clearly show this problem in the method section. Discussion 1. The discussion at times looks a replica of the result and just bring the other studies that looks alike. However, please focused and build on mainly the justification for those differences and learning aspects from the findings 2. At the same time, the research needs to clearly state where this research limitation and strength. How those issues resolved Conclusion and recommendation Can the researcher show clearly, the significance to the public health and policy or implication in broader perspective. What are importance and the contribution from the existing system? can give concert suggestions to make a change based on the evidence of their study. Reviewer #2: Review Report for manuscript number “PONE-D-20-17494” 1) General comments: This study is relevant as it was conducted on preterm birth which is one of the leading causes of neonatal deaths in Ethiopia. However, it needs language revisions throughout the manuscript. Moreover, major changes should be made by taking the provided comments into account. 2) Specific Comments: Abstract: A) Background: Line 27 states that “There were few studies on determinants of preterm birth in Ethiopia…”. I don’t think that. There are a number of studies in Ethiopia in this issue. You would rather mention their gaps. B) Method: Line 37; the term “Data” is plural word. So, replace “was” with “were”. C) Conclusion: please propose certain recommendations based on your key findings. Introduction A) I kindly recommend you to summarize the statement of the problem with 4 paragraphs: 1) the nature of the problem, 2) the known aspects of the problem (causes, magnitude risk factors, intervention (i.e., what is known?)), 3) the unknown aspects (any knowledge, intervention, methodology gaps (i.e., what is unknown?)), and 4) the expectation (s) from this study (i.e., so what?) B) Please work out to improve the coherence. C) I kindly request you for clarification: Line 55-57; it has to be clear in which regions or countries this classification works? For Example, in Ethiopia context, any termination of pregnancy prior to 28 completed weeks of gestational age is termed as "abortion". D) Please correct flaring errors. For example, line 58 states that “about 15 million infant born prematurely.” Herein, please change the infant to its plural form (i.e., infants). Ditto for line 86; change “literatures” to literature. E) Line 64-66; could you please provide information on the aggregate prevalence of preterm birth in Ethiopia. Methods: A) Line 123-125; generally further elaborations would be included regarding the case definition, inclusion and exclusion criteria. The cases and controls would be defined clearly, ‘’ not reliable ultrasonography’ has to be measurable. What measures have been made when gestational age disparity happened across records from LNMP and “early ultrasound”. Have you included post term births to controls? Have you included those preterm births which have been terminated deliberately? In general, ACOG definition would be used. B) Line 128-132; It is not clear why the authors took reference from Ghana for sample size calculation as a number of studies are here in Ethiopia (For instance; look at https://doi.org/10.1155/2020/1854073). Result: A) Line 198-199; “Thirty-nine (22.67%) of cases and 77 (22.38%) of controls had no formal education” please add the article “the” in before “cases” &” controls” B) Line 201-202; “Concerning residence, about two-third of the cases 116 (67.44%) and 214 (62.21%) of the controls were rural dwellers” would be corrected as one of the following: 1) Concerning residence, about 116 (67.44%) of the cases and 214 (62.21%) of the controls were rural dwellers or 2) Concerning residence, about two-third (67.44%) of the cases and three-fifth (62.21%) of the controls were rural dwellers. C) Line 208; “… majority of the study participants, 128 (74.42%) of the cases 253 (73.55%) of the controls …” needs English language editing. D) The regression table (i.e., “table 4”) poses major issues: �One category of occupation is “others”, what “others” stands for? List them by using foot note. �One category of “Marital status” is “widowed”. However, the number of cases in this category is only one and the corresponding 95% CI is too wide (i.e., 0.029, 1.809). In other words, about 1780 differences observed between the upper and lower limit which violates one of the assumptions of the binary logistic regression model. So, I kindly recommend you to merge the some categories of the variables with few numbers of participants in the cases and / or controls. Thereafter, you need to undertake re-analysis provided that all variables which are entered to the model should fulfill the assumptions of the Binary logistic regression model. �About 50 cases and 87 controls were in the age group of 15-24 which implies that minors have been included in the study. If so, how have you addressed the ethical issues? In this occasion, let me raise one another important concern; why have you failed in incorporating a sub-section of “Ethical approval”? �The sum of each category of variables under the cases has to be 100%. Ditto for controls. However, that was not true in your study. This implies that you have considered the “row” percentages in the “crosstab” that is recommended for cross sectional study design. For case – control study design, however, “column” percentages should be reported over “row” percentages. Therefore, you need to address this concern while you perform re-analysis as per the above recommendation. Discussion: Your way of discussion is interesting. However, still it needs revision for language: A) Tense or spelling errors: For instance; line 274; change “remained” to be “remains”, line 309; edit “Gonder” to be “Gondar” B) Certain phrases have been employed frequently. For example “the odds of developing preterm birth...”, “…due to the fact that…” C) Be consistent in using the abbreviations Vs the extended forms. For example; line 302; you have utilized “Pregnancy induced hypertension”, whereas at line 303; you have used its abbreviation for “PIH”, again at line 305, 307, 311…; you have employed its extended form “Pregnancy induced hypertension”???Moreover, the abbreviation “PIH “has not been listed under the “Abbreviations” section. On the contrary, the abbreviation “PIHTN” has been found under the list although it has not been used at the main document at all. I kindly recommend you to put the extended form of each abbreviation followed by its abbreviated form in bracket at its first appearance. Then you can use the abbreviated form alone throughout the document and don’t forget mentioning it at the lists of “abbreviations “section. D) The limitations of your study as well as the efforts made to overcome those limitations would be stated. References: A) Reference 6(line 374-376) & 28 (line 430-432) are similar. B) You would use certain recently published articles. For example “Determinants of Preterm Birth among Women Who Gave Birth in Amhara Region Referral Hospitals, Northern Ethiopia, 2018: Institutional Based Case Control Study”, which is available at https://doi.org/10.1155/2020/1854073 , has not been cited in your manuscript. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Muhabaw Shumye Mihret [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-17494R1 Determinants of preterm birth among women delivered in public hospitals of Western Ethiopia, 2020: Unmatched case-control study PLOS ONE Dear Dr. Abadiga, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We encourage you to let the manuscript be checked for proof-reading by a native English speaker. Please submit your revised manuscript by Jan 22 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Florian Fischer Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: Manuscript number: PONE-D-20-17494R1 This paper has been greatly improved and almost all my concerns have been addressed. However, the manuscript has still certain glaring errors. For example, line 25-26 “…1 million death…and 60% of this death occur in ….” has to be corrected as …1 million deaths… and 60% of these deaths occur in… Therefore, the manuscript needs to be revised for language thoroughly. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Determinants of preterm birth among women delivered in public hospitals of Western Ethiopia, 2020: Unmatched case-control study PONE-D-20-17494R2 Dear Dr. Abadiga, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Florian Fischer Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-17494R2 Determinants of preterm birth among women delivered in public hospitals of Western Ethiopia, 2020: Unmatched case-control study Dear Dr. Abadiga: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Florian Fischer Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .